Catherine M. Albert

2.6k total citations · 1 hit paper
30 papers, 995 citations indexed

About

Catherine M. Albert is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Catherine M. Albert has authored 30 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 9 papers in Pathology and Forensic Medicine and 9 papers in Oncology. Recurrent topics in Catherine M. Albert's work include Sarcoma Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (10 papers) and Neuroblastoma Research and Treatments (6 papers). Catherine M. Albert is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (10 papers) and Neuroblastoma Research and Treatments (6 papers). Catherine M. Albert collaborates with scholars based in United States, France and Germany. Catherine M. Albert's co-authors include Jessica L. Davis, Theodore W. Laetsch, Douglas S. Hawkins, Noah Federman, Erin R. Rudzinski, Steven G. DuBois, Michael C. Cox, Brian Turpin, Leo Mascarenhas and Scott Cruickshank and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Catherine M. Albert

30 papers receiving 974 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

2018 378 citations Theodore W. Laetsch, Steven G. DuBois et al. profile →

Peers

Catherine M. Albert

PRM

ONCOL

NEURO

Brian Turpin United States

Paola Aimone Switzerland

Natalie Vena United States

Hiroshi Haneda Japan

Pierre‐Paul Bringuier France

Piera Federico Italy

Gina Z. D’Amato United States

Barbara Del Curto Italy

Zeng-Feng Wang United States

Akiko Ohashi Japan

Brian Turpin United States

Catherine M. Albert

750 ×1.2

PRM

506 ×1.3

ONCOL

370 ×1.4

NEURO

364 ×1.4

184 ×1.0

Citations per year, relative to Catherine M. Albert Catherine M. Albert (= 1×) peers Brian Turpin

Countries citing papers authored by Catherine M. Albert

Since Specialization

Citations

This map shows the geographic impact of Catherine M. Albert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine M. Albert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine M. Albert more than expected).

Fields of papers citing papers by Catherine M. Albert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine M. Albert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine M. Albert. The network helps show where Catherine M. Albert may publish in the future.

Co-authorship network of co-authors of Catherine M. Albert

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine M. Albert. A scholar is included among the top collaborators of Catherine M. Albert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine M. Albert. Catherine M. Albert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gupta, Ajay, Richard F. Riedel, Scott C. Borinstein, et al.. (2024). Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board. Cancer. 130(23). 4028–4039. 2 indexed citations

Drilon, Alexander, Lin Shen, François Doz, et al.. (2023). 668P Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer. Annals of Oncology. 34. S470–S470. 2 indexed citations

Davis, Lara E., et al.. (2023). Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?. Cancers. 15(20). 5044–5044. 18 indexed citations

Gupta, Ajay, Richard F. Riedel, Chirag Shah, et al.. (2023). Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor Board. Cancer. 129(21). 3363–3371. 6 indexed citations

McDermott, Ray, W. Marston Linehan, Shivaani Kummar, et al.. (2022). 463P Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer with an extended follow-up. Annals of Oncology. 33. S751–S752. 1 indexed citations

Albert, Catherine M., et al.. (2022). Case report of congenital methemoglobinemia: an uncommon cause of neonatal cyanosis. SHILAP Revista de lepidopterología. 8(1). 7–7. 3 indexed citations

Hong, David S., Lin Shen, Cornelis M. van Tilburg, et al.. (2021). Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer.. Journal of Clinical Oncology. 39(15_suppl). 3108–3108. 25 indexed citations

McDermott, Ray, Cornelis M. van Tilburg, Anna F. Farago, et al.. (2020). 1955P Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer. Annals of Oncology. 31. S1101–S1102. 13 indexed citations

DuBois, Steven G., Catherine M. Albert, Leo Mascarenhas, et al.. (2019). A phase I study of LOXO-292, a highly selective RET inhibitor, in pediatric patients with RET-altered cancers.. Journal of Clinical Oncology. 37(15_suppl). TPS10066–TPS10066. 2 indexed citations

10.

Tilburg, Cornelis M. van, Steven G. DuBois, Catherine M. Albert, et al.. (2019). Larotrectinib efficacy and safety in pediatric TRK fusion cancer patients.. Journal of Clinical Oncology. 37(15_suppl). 10010–10010. 12 indexed citations

11.

Ronsley, Rebecca, Shahrad R. Rassekh, Yaoqing Shen, et al.. (2018). Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma. Molecular Case Studies. 4(2). a002568–a002568. 12 indexed citations

12.

Albert, Catherine M., Jessica L. Davis, Noah Federman, Michela Casanova, & Theodore W. Laetsch. (2018). TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening. Journal of Clinical Oncology. 37(6). 513–524. 66 indexed citations

13.

Baheti, Akshay, Teresa Chapman, Erin R. Rudzinski, Catherine M. Albert, & A. Luana Stanescu. (2018). Diagnosis, histopathologic correlation and management of hepatoblastoma: What the radiologist needs to know. Clinical Imaging. 52. 273–279. 9 indexed citations

14.

Tan, Daniel Shao-Weng, Ulrik Lassen, Catherine M. Albert, et al.. (2018). Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach. Annals of Oncology. 29. ix23–ix23. 7 indexed citations

15.

Kerleroux, Basile, et al.. (2018). Ultrasonographic assessment of the internal jugular vein for the estimation of central venous pressure in hemodialysis patients: A preliminary study. Journal of Clinical Ultrasound. 46(4). 253–258. 1 indexed citations

16.

Gallego, Soledad, Michela Casanova, Stefan Bielack, et al.. (2017). Phase 1/2 study of the selective TRK inhibitor larotrectinib, in pediatric patients with cancer. Annals of Oncology. 28. v139–v139. 1 indexed citations

17.

Davis, Jessica L., Christina M. Lockwood, Catherine M. Albert, et al.. (2017). Infantile NTRK -associated Mesenchymal Tumors. Pediatric and Developmental Pathology. 21(1). 68–78. 89 indexed citations

18.

Hayashi, Masanori, David Chu, Christian F. Meyer, et al.. (2016). Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA. Cancer. 122(19). 3015–3023. 57 indexed citations

19.

Goldstein, Seth D., Masanori Hayashi, Catherine M. Albert, Kyle W. Jackson, & David M. Loeb. (2015). An orthotopic xenograft model with survival hindlimb amputation allows investigation of the effect of tumor microenvironment on sarcoma metastasis. Clinical & Experimental Metastasis. 32(7). 703–715. 31 indexed citations

20.

Hayashi, Masanori, et al.. (2013). Onco-fertility care in a children's hospital: A quality improvement initiative.. Journal of Clinical Oncology. 31(31_suppl). 41–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact